C1 Introduction for Genzyme

Partners in powerful biopharma commercial

decisions

Unlock Insights. Activate Growth.

May, 2015

C1: Your strategic partner in highly specialized pharma

commercial
decisionsin a specialized and challenging pharma market, you are faced
As a commercial decision-maker
with thousands of decisions along the lifecycle of your business. From discovery to launch to peak
performance, your decisions impact the value of your business, and you take pride in getting it
right every time, staying several steps ahead of the competition.

Business Performance

Leverage
Leverage C1
C1 experience
experience for
for
agile
agile and
and evidence-based
evidence-based
commercial
commercial decisions,
decisions, and
and
gain
competitive
gain competitive
advantage.
advantage.

?ABAB

Each of the 1000s of

decisions?you face
represent an
opportunity to
increase value.

Traditional

Brand and Business

Lifecycle
Establish
successful
foundation
2

Prepare
the
market

Prepare
the launch

Accelerate
uptake

Maximize
peak sales

It takes more than good data and reporting to see into future.
The right data and analytics tools are key to unlocking
competitive
advantage
in biopharma
Todays pharmaceutical
and biotech markets
are complex and insights from data can be elusive.
Advanced analytics benefits include: 1) enhanced market understanding, 2) better decisionmaking, and 3) increased ROI.

Competitive Advantage

Most companies are proficient hereMany companies struggle here

What
What has
has
happened?
happened?

Strategy
Optimizatio
n

How will you plan for future

market scenarios to stay a
step ahead of competitors?

Predictive
Modeling

How will you optimize

overall brand performance
across different channels,
and across geographies?

Untangling
competitive
dynamics
and
performanc
Market
e
understandin
Reporting
g (customer
on historical
level)
data
(retrospectiv
e)
Evolving Decision Making Maturity
Descriptive
Descriptive

Diagnostic
Diagnostic
Why
Why did
did that
that
happen?
happen?

Evidence-based and agile

commercial decisions:

Predictive
Predictive
What
What might
might
happen?
happen?

Prescriptive
Prescriptive

How
How can
can we
we make
make
it
it happen?
happen?

How will you evaluate the

robustness of your
strategic plan vis--vis
future market events and
potential competitor
reactions?
How will your commercial
decisions outpace change
in your market?
We have an 11-year
proven record of
optimizing our clients
strategies through
market understanding
and advanced analytics.

The right solution for addressing your specific commercial

challenge takes matching relevant senior commercial
experience with experienced data science horsepower
At C1 we
Understand our clients challenges and direct the right
solutions to solve them
Unlock Insights. Activate Growth.

C1 at a
Glance

Founded in 2004

Bolster competitive advantage by valuing market

opportunities, commercializing new products, and
improving brand performance

Disease area experts in rare

disease, oncology, immunology,
neurology, and specialty
biopharma

Employ hands-on senior staff through every phase of the

project. These senior leaders have lived your decisions
and challenges and bring practical and actionable
insights to increase shareholder value

Issue area experts in Big Data

and predictive analytics

Guide evidence-based brand strategy that dissects key

market dynamics, driving improved decision making

60+ team members in 4 offices

Hands on senior leadership from
industry and top analytics firms
Established track record of high
quality and value based on repeat
work
4

Integrate advanced analytics and consulting methods to

deliver strategic recommendations for brand planning
and forecasting

Client recommendations are

available

Meet the C1 Team

The C1 leadership team has an average of over 20 years of experience in the pharmaceutical
industry and in commercial settings requiring advanced analytics

Rob Sederman | Summit, NJ

Elizabeth Rountree | San Francisco/Lucerne

Managing Director, Advanced Analytics Practice Lead

Managing Director

Co-founder of C1 in 2004
25+ years data and analytics expertise in Pharma/Biotech
Prior Executive Positions at ZS Associates, NOP World
Health
MBA (Harvard Business School) and BS in Operations
Research (USAFA)

20+ years customer insights experience (data, analytics,

primary market research) in biopharmaceuticals
In-depth expertise in Neuroscience and Oncology
Prior Executive Positions at Cozint, NOP World Health
MBA (Darden) and BA (Emory)

Kevin Brubacher | Atlanta, GA

Ned Kitfield | New York, NY

Partner and Strategy Practice Lead

Partner and Rare Disease Practice Lead

Joined C1 in 2011
25+ years of hands-on Pharma/Biotech commercial
experience
Senior Director, Global Marketing, Vertex
Group Marketing Director, UCB
Director of New Product Commercialization, Celltech
BS (University of Western Ontario)

Joined C1 in 2014
20+ years of hands-on Pharma/Biotech commercial
experience
Senior Director, Global Commercial Operations, Shire
Global Commercial Lead, Shire Human Genetic Therapies
Sales Director, Adolor Corporation
MBA (U Mass) and BA (McGill)

Robert Broadnax | Summit, NJ

Director and Oncology Practice Lead
Joined C1 in 2015
16+ years Pharma/Biotech Commercialization, Sales & Analytics
Experience
Director, Worldwide Hematology Franchise Lead, BMS
Director, European Brand Lead, BMS
Roche, Bristol-Myers Squibb, UCB & TRM Oncology
BChe (Georgia Tech)

Our teams are staffed by highly motivated talent with over

50
+
+

PhDs, MBAs, MPHs,

or other masters
degrees

10
+
+

avg. years management

consulting experience

10
+
+

avg. years advanced

analytics experience

10
+
+

avg. years
pharmaceutical
industry experience

Benefits to Genzyme of a C1 partnership

You
You will
will be
be
supported
supported by
by senior
senior
level
level core
core team
team
C1
C1 knows
knows rare
rare
disease
disease

Your core team will consist of senior level

consultants with decades of global
pharmaceutical marketing and consulting
experience
C1 Consulting has completed a broad spectrum
of projects with multiple companies operating in
the rare disease space and we understand the
unique needs that may arise

Much
Much more
more value
value
than
than answering
answering
questions
questions

C1 delivers strategic insights and

recommendations based on our experience and
knowledge of your brands and your priority
markets. We do not stop at merely collecting
information

C1
C1 =
= Customers
Customers first
first

C1s business is sustained and grows based on

satisfied clients

A
A partnership
partnership with
with C1
C1 means
means harnessing
harnessing excellence
excellence in
in rare
rare disease,
disease,
decades
decades of
of business
business experience
experience and
and pharmaceutical
pharmaceutical insight,
insight, and
and a
a
client-first
client-first approach
approach
6

Every strategic decision is important and affects all your future

You
strive for competitive advantage and agility in your strategic decisions. C1 takes great care and
decisions
ownership in the responsibility of partnering with bio-pharmaceutical clients to ensure every
decision is evidence and experience based.

Advanced Analytics
Highly-informed and
thoughtful data choices
Customer insights
Powerful and logical data
integration
Leading edge analytics
Predictive modeling
Simulation tools

Informing Strategy
Decisions
Pipeline
Pre-launch
On-market
Business development
Experience with a variety of
internal processes and
complexities
Brand and Medical Planning

Expert Commercial
Counsel
Highly-experienced partners
Curiosity and interpretation
Polished and leadershipready reports
Responsible teams with
accountability and integrity

C1 core therapeutic areas of focus

Rare Disease

Oncology

Neuroscience

Immunology

Specialty
Biopharma

C1 does not sell data. Our decision to remain independent of any business
relationship with data sources is part of our commitment to objectivity for
your strategy.
7

Connect with C1
C1 is excited to partner with Genzyme, to build a lasting relationship. Please contact:

Ned Kitfield
email | ned@c1consulting.com
mobile | +1 617-270-3311

Client Testimony
I have been using C1 for over two years now and they have quickly become a preferred
partner for our analytical and consulting work. What I think sets them apart is their
ability to bring, analyze and translate evidence into highly relevant insights and
actionable recommendations. They have become an integral part of our teams thanks to
their ability to span knowledge and communications with different stakeholders: marketing,
research, clinical development, competitive intelligence, forecasting, and even sales. More
importantly, they do not cut corners, we always get hands on senior involvement.
--Client, Director, Pipeline Strategy and Development, US

Contact Information
Rob Sederman
rob@c1consulting.com
mobile | 609.335.2681
Summit, NJ

Elizabeth Rountree
elizabeth@c1consulting.com
mobile | 609.273.3194
San Francisco, CA

Kevin Brubacher
kevin@c1consulting.com
mobile | 678.799.2994
Atlanta, GA

Ned Kitfield
ned@c1consulting.com
mobile | 617.270.3311
New York, NY

www.c1consulting.
com

find C1 on Linke
dIn

This document, together with any attachments, contains proprietary information of C1 Consulting, LLC, that may be confidential, proprietary copyrighted and or legally
privileged. It is intended solely for the use of the individual or named entity. If you are not the intended recipient and have received this document in error, please delete it,
along with any copies and attachments from your system. Any unauthorized disclosure, use, distribution or reproduction of this document or any attachments is prohibited
and may be unlawful.